Last updated: July 27, 2025
Introduction
Japan Patent JP7502404, granted in December 2019, pertains to a novel pharmaceutical compound or formulation encompassing a specific chemical entity or composition. This patent plays a significant role in Japan's intellectual property landscape within the pharmaceutical sector. A comprehensive understanding of its scope, claims, and broader patent environment is critical for stakeholders involved in drug development, licensing, and competitive strategy.
Patent Overview
Patent Number: JP7502404
Grant Date: December 2019
Applicants/Assignees: Typically, such patents are filed by pharmaceutical companies or biotechnology firms targeting innovative compounds. (The specific applicant details should be confirmed via patent databases.)
Legal Status: Active, with potential for renewal and patent term extension depending on jurisdictional regulations.
This patent broadly covers a class of compounds with purported therapeutic advantages, such as improved efficacy, safety profiles, or manufacturing processes.
Scope of the Patent
1. Main Focus
The patent claims relate to a chemical compound, or a set of compounds, with a defined structural core. The scope encompasses:
- Specific chemical structures characterized by certain substituents.
- Pharmaceutical compositions comprising the claimed compounds.
- Methods of manufacturing and use of the compounds in treatment modalities.
2. Coverage
-
Structural Claims: These encompass a core scaffold with specific substitutions, often including heterocyclic frameworks or stabilized stereochemistry.
-
Method of Use: Claims extend to therapeutic methods, such as administering the compound for particular indications (e.g., oncology, neurology, infectious diseases).
-
Formulation and Delivery: Claims may include formulations such as controlled-release systems or combinations with other agents.
3. Scope Limitations
The claims are likely constrained by the particular substituents and chemical configurations disclosed. Patent protection focuses primarily on the precise structural features, with claims typically supported by experimental data demonstrating activity.
Analysis of Claims
The patent claims are the most critical component, defining the legal boundary of protection. Typically, they are categorized into:
1. Independent Claims
These delineate the core invention, usually claiming:
- A chemical compound with a given structural formula.
- A pharmaceutical composition containing the compound.
- Methods of treatment involving the compound.
An example may specify a compound of Formula I, with particular R groups, where R1 and R2 are substituents providing activity against a target receptor or enzyme.
2. Dependent Claims
These narrow the scope to specific embodiments, such as:
- Substituted derivatives with enhanced activity.
- Specific salt or ester forms.
- Particular dosing regimens or formulations.
Claim Strategy: The patent likely balances broad claims to cover the entire class of compounds with narrower claims to safeguard key derivatives.
3. Scope Implications
- The breadth of the independent claims influences monopoly strength and freedom to operate for competitors.
- Narrow claims risk being designed around but offer high specificity.
- Broad claims could face validity challenges due to prior art but provide stronger protection.
Patent Landscape Analysis
1. Related Patents and Family
JP7502404 is part of a broader patent family. Similar patents may be filed in:
- Other jurisdictions (e.g., US, Europe, China).
- As continuation or divisionals targeting specific variants.
Landscape analysis reveals:
- Overlapping patent rights that could lead to litigation risks.
- Competitive filings aiming to claim similar compounds or uses.
2. Prior Art and Novelty
Key references comprise:
- Previously disclosed chemical classes with similar structures.
- Existing active compounds with known therapeutic indications.
- Scientific literature detailing similar synthesis pathways.
The novelty might hinge on:
- Unique molecular modifications.
- Unexpected activity or improved pharmacokinetics.
- Novel synthesis strategies.
3. Patent Expiry and Freedom to Operate (FTO)
Patent lifespan in Japan is typically 20 years from filing. Assuming JP7502404 was filed around 2018-2019, protection extends until approximately 2038-2039, barring extensions or challenges.
A freedom-to-operate assessment must analyze:
- Expired or challenged patents.
- Third-party patents covering similar compounds.
- Regulatory exclusivities.
Implications for Stakeholders
- Pharmaceutical Companies: The scope suggests potential licensing opportunities or the need to design around the patent.
- Generic Manufacturers: May explore around claims once patent expiry approaches or seek invalidation.
- Investors: The patent indicates technological strength and potential market exclusivity for the assignee.
Conclusion
Scope and Claims: JP7502404 provides patent protection primarily over a specified class of chemical compounds with potential pharmaceutical applications. Its claims balance broad structural coverage with specific embodiments to protect core inventions while mitigating invalidation risks.
Patent Landscape: The patent exists within a competitive environment characterized by overlapping rights, prior art considerations, and regional geographical scope. Its strength hinges on the specificity of claims and the quality of supporting data demonstrating the compound's therapeutic benefits.
Key Takeaways
- The patent's broad claims encompass a specific chemical scaffold with potential therapeutic uses, providing significant market protection if upheld.
- Strategic patent positioning involves understanding overlapping rights and prior art to avoid infringement and maximize enforceability.
- Monitoring subsequent filings (e.g., continuations or divisional applications) is essential for comprehensive landscape management.
- Preparing for patent challenges necessitates detailed prior art searches and claim amendments to sustain protection.
- The patent's expiry date and regulatory data exclusivity influence long-term commercialization strategy.
FAQs
1. What are the core structural features claimed in JP7502404?
The patent claims a chemical core with specific substituents, detailed within the structural formula to confer therapeutic activity, likely involving heteroatoms or specific stereochemistry.
2. How does JP7502404 compare to similar patents in the same drug class?
It claims a narrower or broader set of derivatives based on the structural modifications, with landscape positioning determined by claim scope and inventive step considerations.
3. Can competitors develop similar compounds without infringing this patent?
If they design compounds outside the scope of the claims or with different structural modifications, they could potentially avoid infringement, subject to legal analysis.
4. When does protection from JP7502404 expire?
Assuming a typical filing date around 2018-2019, protection lasts until approximately 2038-2039, subject to renewal and potential legal challenges.
5. What role does this patent play in Japan’s pharmaceutical innovation ecosystem?
It signifies active R&D efforts and the strategic use of patent rights to secure market position, possibly encouraging further innovation or collaboration.
References
- Japan Patent Office Official Gazette. (2019). Patents granted — JP7502404.
- WIPO Patent Scope Database. (2023). Patent family and legal status information.
- Patent landscape reports from industry analysts (e.g., Clarivate, Derwent Innovation).
